FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates

Leukemia
C Lavagna-SévenierO Rosnet

Abstract

Proliferation and survival of hematopoietic progenitors are partially dependent on the interaction between the FLT3 receptor tyrosine kinase (RTK) and its ligand, FL. This biological function depends primarily on tyrosine phosphorylation of cellular targets that initiate several transduction cascades. These events return to their basal levels upon activation of specific phosphatases. We analyzed tyrosine phosphorylation events in response to FL, in human cell lines of different hematopoietic origins that express endogenous FLT3, namely the myelomonocytic, monocytic, pre-B and pro-B lineages. This study aimed at determining (1) the identity of FLT3 downstream substrates in physiologically relevant cells and (2) distinct substrate involvement in myeloid or early B cells. The two prominent tyrosine-phosphorylated proteins are p52SHC and p115CBL in myeloid cell lines and p52SHC and an uncharacterized p115 in early B cell lines. Following FL stimulation, a concomitant increase in both CBL phosphorylation and complex formation with p85 subunit of phosphatidylinositol 3' kinase is observed. In contrast, the GRB2/CBL association observed in unstimulated cells is not modified after stimulation, and SHC is never detected in anti-CBL immu...Continue Reading

Citations

Mar 11, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Brown, D Small
Oct 12, 2013·Immunology Letters·M MianoC Dufour
Sep 3, 2003·Nature Reviews. Cancer·Derek L Stirewalt, Jerald P Radich
Jun 4, 2002·Current Opinion in Hematology·D Gary Gilliland, James D Griffin
Jun 25, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Soheil Meshinchi, Frederick R Appelbaum
May 19, 2009·American Journal of Respiratory Cell and Molecular Biology·Halvor S McGeeDevendra K Agrawal
Sep 9, 2005·International Journal of Hematology·Chunaram ChoudharyHubert Serve
Oct 12, 2000·Biochemical and Biophysical Research Communications·S Zhang, H E Broxmeyer
Nov 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Katharine A WhartenbyDonald Small
May 3, 2008·Leukemia & Lymphoma·Keith Pratz, Mark Levis
Dec 4, 2003·Expert Opinion on Investigational Drugs·Mark Levis, Donald Small
Jul 28, 2007·British Journal of Haematology·Steven Knapper
Oct 21, 2005·Critical Reviews in Oncology/hematology·Björn SteffenHubert Serve
Oct 9, 2014·Frontiers in Oncology·Colleen E Annesley, Patrick Brown
Sep 2, 2016·Biochemistry·Safnas F AbdulSalamEdward J Merino
Jan 21, 2017·Leukemia Research·Ayuna HattoriTakahiro Ito
May 26, 2017·International Journal of Molecular Sciences·Panagiotis TsapogasAntonius Rolink
May 29, 2002·Oncogene·Blanca Scheijen, James D Griffin
Dec 3, 2004·The Journal of Biological Chemistry·Peili ChenDonald Small
Sep 13, 2003·Leukemia·M Levis, D Small
Sep 9, 2005·International Journal of Hematology·Hitoshi KiyoiKazutaka Ozekia
Jul 25, 2003·Oncogene·Nathalie CasteranPatrice Dubreuil
Oct 19, 2001·Oncogene·A Y TsygankovG Swaminathan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.